论文信息 - Phase II study of ipilimumab, nivolumab, and panitumumab in patients with KRAS/NRAS/BRAF wild-type (WT) microsatellite stable (MSS) metastatic colorectal cancer (mCRC). - 字舞流文

Phase II study of ipilimumab, nivolumab, and panitumumab in patients with KRAS/NRAS/BRAF wild-type (WT) microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

H. Sanoff | K. Ciombor | P. Loehrer | A. McRee | Michael S. Lee | I. Imanirad | Cheryl A Carlson | S. Cohen | D. Moore